Literature DB >> 18256110

The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.

Mei-Jou Chen1, Wei-Shiung Yang, Chi-Ling Chen, Ming-Yih Wu, Yu-Shih Yang, Hong-Nerng Ho.   

Abstract

BACKGROUND: Anti-Müllerian hormone (AMH) is a biomarker that predicts the number of antral follicles and is involved in follicle arrest for women with polycystic ovary syndrome (PCOS). We investigated the association between the characteristic hyperandrogenemia, insulin resistance (IR), AMH, and the morphology and size of ovaries for women with PCOS.
METHODS: A total of 99 Taiwanese women with PCOS who were willing to undergo vaginal ultrasonography were enrolled in this cross-sectional study.
RESULTS: The number of antral follicles and the ovarian volume showed a significant correlation with AMH, total testosterone and the free androgen index, but not with age, body mass index (BMI) or the homeostasis model assessment of insulin resistance (HOMA-IR). AMH had a significant negative association with both BMI and HOMA-IR. Multiple stepwise regression analysis demonstrated that AMH, BMI and total testosterone were independently related to the number of antral follicles. AMH and total testosterone were the main determinants for ovarian volume in a stepwise regression model.
CONCLUSIONS: Our results suggest that not only the AMH level, but also obesity, IR and elevated androgen levels may relate to the development of the large size of antral follicle pool and ovarian volume in women with PCOS. Obesity and IR may enhance the follicular excess through the dysregulation of AMH or through the pathway of hyperandrogenemia. These findings might partly explain why adequate body weight management and improvement in IR can improve the ovulatory function for women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256110     DOI: 10.1093/humrep/den015

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

1.  Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

Authors:  W K McGee; C V Bishop; A Bahar; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Hum Reprod       Date:  2011-11-23       Impact factor: 6.918

2.  Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Jacob P Christ; Tommaso Falcone
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.

Authors:  Alice S Park; Mark A Lawson; Sandy S Chuan; Sharon E Oberfield; Kathleen M Hoeger; Selma F Witchel; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2010-02-11       Impact factor: 5.958

4.  Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study.

Authors:  Zaher O Merhi; David B Seifer; Jeremy Weedon; Oluwatoyin Adeyemi; Susan Holman; Kathryn Anastos; Elizabeth T Golub; Mary Young; Roksana Karim; Ruth Greenblatt; Howard Minkoff
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

5.  The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

Authors:  Erica B Johnstone; Mitchell P Rosen; Rebecca Neril; Deborah Trevithick; Barbara Sternfeld; Rosemary Murphy; Carolyne Addauan-Andersen; Daniel McConnell; Renee Reijo Pera; Marcelle I Cedars
Journal:  J Clin Endocrinol Metab       Date:  2010-08-18       Impact factor: 5.958

6.  Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin.

Authors:  Angela Falbo; Morena Rocca; Tiziana Russo; Antonietta D'Ettore; Achille Tolino; Fulvio Zullo; Francesco Orio; Stefano Palomba
Journal:  J Ovarian Res       Date:  2010-07-21       Impact factor: 4.234

7.  Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.

Authors:  Julie S Rios; Eleni A Greenwood; Mary Ellen G Pavone; Marcelle I Cedars; Richard S Legro; Michael P Diamond; Nanette Santoro; Fangbai Sun; Randal D Robinson; Gregory Christman; Heping Zhang; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

8.  Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys.

Authors:  D A Dumesic; M S Patankar; D K Barnett; T G Lesnick; B A Hutcherson; D H Abbott
Journal:  Hum Reprod       Date:  2009-09-09       Impact factor: 6.918

9.  Serum anti-müllerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index.

Authors:  Sezai Sahmay; Onur Guralp; Levent M Senturk; Metehan Imamoglu; Mustafa Kucuk; Tulay Irez
Journal:  Reprod Med Biol       Date:  2011-03-05

10.  Age-group-specific reference intervals for anti-Müllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population.

Authors:  Junhyup Song; Yongjung Park; Hae Weon Cho; Sang-Guk Lee; Sinyoung Kim; Jong Baeck Lim
Journal:  J Clin Lab Anal       Date:  2021-06-07       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.